Drug-induced Brugada syndrome
Open Access
- 29 May 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 11 (8), 989-994
- https://doi.org/10.1093/europace/eup114
Abstract
Brugada syndrome is an inherited cardiac arrhythmia condition characterized by (i) coved ST-elevation and J point elevation of at least 2 mm in at least two of the right precordial ECG leads (V1–V3) and (ii) ventricular arrhythmias, syncope, and sudden death. Patients with Brugada syndrome or suspected mutation carriers can have normal ECG recordings at other times. In these cases, a diagnostic challenge with a sodium channel blocker such as ajmaline, flecainide, or pilsicainide may induce the full-blown type 1 ECG pattern and support the diagnosis. However, recently, many other pharmacological agents not related to class I anti-arrhythmic agents have been reported to induce Brugada ECG patterns including tricyclic antidepressants, fluoxetine, lithium, trifluoperazine, antihistamines, and cocaine. As published reports of the drug-induced Brugada sign have become increasingly prevalent, there is growing interest in the mechanisms responsible for this acquired ECG pattern and its clinical significance. It is possible that drug-induced Brugada syndrome may be due to an individual susceptibility that favours drug-induced ECG abnormalities, possibly as a result of an increase in a latent ion channel dysfunction similar to that in drug-induced long QT syndrome. However, further evidence is needed to confirm this postulation. In this paper, we will review the cases and evidence of drug-induced Brugada syndrome reported in the literature.Keywords
This publication has 59 references indexed in Scilit:
- Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene ( GPD1-L ) Decreases Cardiac Na + Current and Causes Inherited ArrhythmiasCirculation, 2007
- Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohortHeart Rhythm, 2007
- Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac DeathCirculation, 2007
- Brugada electrocardiographic pattern due to tricyclic antidepressant overdoseJournal of Electrocardiology, 2006
- Brugada Syndrome: Report of the Second Consensus ConferenceCirculation, 2005
- Role of sodium and calcium channel block in unmasking the Brugada syndromeHeart Rhythm, 2004
- Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in MalesCirculation, 2002
- Brugada syndrome and sudden cardiac death in childrenThe Lancet, 2000
- Genetic basis and molecular mechanism for idiopathic ventricular fibrillationNature, 1998
- Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndromeJournal of the American College of Cardiology, 1992